✦ LIBER ✦

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin’s lymphoma

✍ Scribed by Blystad, A K; Kvalheim, G; Torlakovic, E; Holte, H; Jacobsen, E; Beiske, K; Vålerhaugen, H; Lenschow, E; Kvaløy, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous bone marrow transplantation w

✍ L. De Rosa; M. Lalle; A. Pandolfi; C. Ruscio; R. Amodeo 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 156 KB

High-dose therapy followed by bone marro

✍ H. C. Schouten; J. J. M. Raemaekers; J. C. Kluin-Nelemans; H. van Kamp; W. A. M. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 178 KB

Low doses of rIL2 after autologous bone

✍ D. Raspadori; F. Lauria; M. A. Ventura; P. L. Tazzari; S. Ferrini; M. C. Miggian 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 645 KB

Rituximab (anti-CD20 monoclonal antibody

✍ Tsai, D E; Moore, H C F; Hardy, C L; Porter, D L; Loh, E Y; Vaughn, D J; Luger, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

High dose chemotherapy with autologous s

✍ Marianne B. Eide; Grete F. Lauritzsen; Gunnar Kvalheim; Arne Kolstad; Unn M. Fag 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Phase-I–II study of high-dose melphalan

✍ B. Mascret; D. Maraninchi; J. A. Gastaut; D. Baume; G. Sebahoun; C. Lejeune; G. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 587 KB